4967 — Kobayashi Pharmaceutical Share News
0.000.00%
Last trade - 00:00- ¥541bn
- ¥477bn
- ¥166bn
Brief: Kobayashi Pharma Company Has Been Informed Of 2 More Deaths Of Users Of Red Yeast Rice Supplement, Investigating Linkage
Brief: Kobayashi Pharma Says Recalled Products Not Available For Sale In Mainland China Market
Newscasts - Japanese firm recalls dietary pills after deaths
Newscasts - Japanese firm recalls dietary pills after deaths
Kobayashi Pharma ordered to recall red yeast rice pills after 2 deaths
Brief: Japan Chief Cabinet Secretary Hayashi: Health Ministry Hearing Found That There Have Been Two Deaths Related To Kobayashi Pharma's Beni-Koji Product
Brief: Japan Chief Cabinet Secretary Hayashi: Regrettable It Took Kobayashi Pharmaceutical Two Months To Announce Beni-Koji Red Yeast Rice Products' Health Impacts
Have Discovered One Case Of Death Apparently Caused By Beni-Koji Product
Looking Into Impact Of Beni-Koji Product Recalls On 2024 Financial Results
Recalling "Beni Koji" Supplement Products After Receiving Reports Of Some Kidney Ailment Cases From Users
Brief: Kobayashi Pharmaceutical: Built New Plant In Anhui, China To Increase Toiletry Sales In China, With 6 To 9 Billion Yen Investment
Table: Kobayashi Pharmaceutical -2023 group results
Brief: Kobayashi Pharmaceutical: Bought Back 2.53% Of Own Outstanding Shares Worth About 12 Billion Yen On Wednesday Via ToSTNeT-3
Table: Kobayashi Pharmaceutical - 9-MTH group results
Acquired All Shares Of U.S.-Based Focus Consumer Healthcare For $75 Million To Expand In North America
Brief: Kobayashi Pharmaceutical: To Invest 5-10 Billion Yen To Expand Disposable Body Warmer Packet Production Capacity At Plant In Georgia, U.S.
Table: Kobayashi Pharmaceutical - 6-MTH group results
Table: Kobayashi Pharmaceutical -Q1 group results
Table: Kobayashi Pharmaceutical -2022 group results